Evidence map›Paper›PMID 35053394›Full record

ArticleCells2022

Assessment of the Impact of Post-Thaw Stress Pathway Modulation on Cell Recovery following Cryopreservation in a Hematopoietic Progenitor Cell Model.

John M Baust, Kristi K Snyder, Robert G Van Buskirk, John G Baust

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Cryopreservation and Thawing ofJournal of hematology · 2026
    Article
  5. Article
  6. Article
  7. Current Role of CAR-T Therapy in Haematological Care.Advances in experimental medicine and biology · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

John M BaustCPSI Biotech, 2 Court St., Owego, NY 13827, USA.ORCID 0000-0003-0867-8062
Kristi K SnyderCPSI Biotech, 2 Court St., Owego, NY 13827, USA.
Robert G Van BuskirkCPSI Biotech, 2 Court St., Owego, NY 13827, USA.
John G BaustCenter for Translational Stem Cell and Tissue Engineering, Binghamton University, 4400 Vestal Parkway East, Binghamton, NY 13902, USA.
Binghamton University · US

Funding

The SmartBio System for the Improved Preservation of Human Hematopoietic Stem CellsR44HL130805 · NHLBI · CELL PRESERVATION SERVICES, INC. · PI BAUST, JOHN M · 2018 to 2019
$1.3M
NIH HHS 5R44HL130805-03
6 · The paper itself

Abstract

The development and use of complex cell-based products in clinical and discovery science continues to grow at an unprecedented pace. To this end, cryopreservation plays a critical role, serving as an enabling process, providing on-demand access to biological material, facilitating large scale production, storage, and distribution of living materials. Despite serving a critical role and substantial improvements over the last several decades, cryopreservation often remains a bottleneck impacting numerous areas including cell therapy, tissue engineering, and tissue banking. Studies have illustrated the impact and benefit of controlling cryopreservation-induced delayed-onset cell death (CIDOCD) through various "front end" strategies, such as specialized media, new cryoprotective agents, and molecular control during cryopreservation. While proving highly successful, a substantial level of cell death and loss of cell function remains associated with cryopreservation. Recently, we focused on developing technologies (

Indexed as

CryopreservationModels, BiologicalStress, PhysiologicalCell LineCell SurvivalFreezingHematopoietic Stem CellsHumansapoptosiscryopreservationdelayed onset cell deathrecoveryRevitalICEviability

Identifiers

PMID35053394
PMCPMC8773610
OpenAlexW4205824538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.